ADMA BIOLOGICS, INC. Tax Adjustments, Settlements, and Unusual Provisions
ADMA BIOLOGICS, INC. (ADMA) reported Tax Adjustments, Settlements, and Unusual Provisions of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2024-11-07
- ADMA BIOLOGICS, INC. tax adjustments, settlements, and unusual provisions for the quarter ending 2024-09-30 was $0.00.
- ADMA BIOLOGICS, INC. tax adjustments, settlements, and unusual provisions for the quarter ending 2024-06-30 was $0.00.
- ADMA BIOLOGICS, INC. tax adjustments, settlements, and unusual provisions for the quarter ending 2023-09-30 was $0.00.
- ADMA BIOLOGICS, INC. tax adjustments, settlements, and unusual provisions for the quarter ending 2023-06-30 was $0.00.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |